BLLN

Billiontoone Inc

113.82

Oct 28 • 6:51 AM ET -0.25 (-0.22%)

Healthcare Diagnostics & Research USA Mid NASD

Peers: NTRA GH MYGN LH WGS DGX CDNA GRAL NEO FLGT

| Held by: VTI VB VBK VXF SCHA LFSC IHF XHS SMLF ITOT

Index	-
Market Cap	5.37B
Enterprise Value	4.97B
Income	31.95M
Sales	397.41M
Book/sh	11.46
Cash/sh	11.63
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	713
IPO	Nov 06, 2025

P/E	184.74
Forward P/E	113.37
PEG	0.86
P/S	13.51
P/B	9.93
P/C	9.79
P/FCF	161.92
EV/EBITDA	89.32
EV/Sales	12.50
Quick Ratio	11.31
Current Ratio	11.69
Debt/Eq	0.27
LT Debt/Eq	0.26
Option/Short	Yes / Yes

EPS (ttm)	0.62
EPS next Y	1.00
EPS next Q	0.15
EPS this Y	454.13%
EPS next Y	29.41%
EPS next 5Y	131.37%
EPS past 3/5Y	- -
Sales past 3/5Y	106.24% -
EPS Y/Y TTM	201.39%
Sales Y/Y TTM	90.12%
EPS Q/Q	2789.09%
Sales Q/Q	64.40%
Earnings	Nov 04 AMC
EPS/Sales Surpr.	-18.17% 0.17%

Insider Own	49.20%
Insider Trans	-1.93%
Inst Own	28.74%
Inst Trans	4.57%
ROA	6.13%
ROE	9.05%
ROIC	4.74%
Gross Margin	71.27%
Oper. Margin	10.90%
Profit Margin	8.04%
SMA20	10.60%
SMA50	10.53%
SMA200	18.25%
Trades

Shs Outstand	42.28M
Shs Float	23.97M
Short Float	12.23%
Short Ratio	4.45
Short Interest	2.93M
52W High	150.44 -24.34%
52W Low	61.96 83.70%
Volatility	4.85% 6.49%
ATR (14)	5.79
RSI (14)	60.86
Beta	-
Rel Volume	0.07
Avg Volume	658.95K
Volume	2,185

Perf Week	8.74%
Perf Month	-3.69%
Perf Quarter	-18.46%
Perf Half Y	54.42%
Perf YTD	39.08%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.25
Target Price	129.00
Prev Close	114.07
Price	113.82
Change %	-0.22%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-02-26	Initiated	Canaccord Genuity	Buy	$120
Jan-06-26	Initiated	Guggenheim	Buy	$120
Dec-01-25	Initiated	William Blair	Outperform
Dec-01-25	Initiated	Wells Fargo	Equal Weight	$110
Dec-01-25	Initiated	Stifel	Buy	$145
Dec-01-25	Initiated	Piper Sandler	Overweight	$150
Dec-01-25	Initiated	JP Morgan	Overweight	$150
Dec-01-25	Initiated	Jefferies	Hold	$117
Dec-01-25	Initiated	BTIG Research	Buy	$160

Oct-27-26 08:43PM	BillionToOne Must Show Its Second-Quarter Stall Was Payer Timing, Not Peak Growth (Earnings Whispers)
08:05AM	BillionToOne to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Oct-21-26 04:59PM	7 healthcare stocks that stand out as investors pay up for the sector (MarketWatch)
Oct-14-26 08:05AM	BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026 (GlobeNewswire)
Oct-07-26 07:00AM	BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds (GlobeNewswire)
04:06AM	Loading…
Sep-23-26 04:06AM	BillionToOne Stock Jumped 12% Yesterday. Heres What the Streets Target. (TIKR)
Sep-02-26 04:05PM	BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference (PR Newswire)
Sep-01-26 09:00AM	BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin (PR Newswire)
Aug-18-26 12:08PM	Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions (PR Newswire) -6.30%
Aug-06-26 04:20PM	Why BillionToOne Plummeted 38%, Leading A Medtech Sell-Off (Investor's Business Daily) -38.89%
01:09AM	BillionToOne Inc (BLLN) (Q2 2026) Earnings Call Highlights: Revenue Surges 64% as Oncology and ... (GuruFocus.com)
Aug-05-26 05:33PM	BillionToOne: Q2 Earnings Snapshot (Associated Press) +5.43%
04:05PM	BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance (GlobeNewswire)
Aug-04-26 09:32AM	BillionToOne Inc (BLLN) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-03-26 12:45PM	Read Between These Lines As Eli Lilly, Hot IPO And More Face Key Test (Investor's Business Daily)
09:00AM	Loading…
Jul-20-26 09:00AM	BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar (PR Newswire)
Jul-15-26 08:05AM	BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire)
Jun-29-26 12:39PM	BillionToOne's Northstar Response Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study (PR Newswire)
Jun-22-26 04:02PM	As SpaceX Slides, This IPO Stock Sparks A Positive Prognosis (Investor's Business Daily)
Jun-05-26 08:05AM	Dow Jones Futures Rise, Techs Fall As AI Trade Cools; Jobs Report Looms (Investor's Business Daily) -7.08%
May-27-26 04:05PM	BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference (GlobeNewswire) +7.74% +7.45%
May-06-26 05:03PM	BillionToOne: Q1 Earnings Snapshot (Associated Press) +14.13%
04:05PM	BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance (GlobeNewswire)
May-01-26 07:00PM	BillionToOne Launches Unity Confirm: A category-defining test that bridges the gap between screening and invasive diagnostics (PR Newswire) -6.93%
Apr-15-26 08:05AM	BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 (GlobeNewswire)
Apr-02-26 09:00AM	BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology (PR Newswire)
Mar-06-26 07:03AM	What Makes BillionToOne (BLLN) an Attractive Bet? (Insider Monkey)
Mar-05-26 12:01AM	BillionToOne Inc (BLLN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) -10.71%
Mar-04-26 07:00PM	Billiontoone Q4 Earnings Call Highlights (MarketBeat)
06:00PM	BillionToOne (BLLN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:38PM	Loading…
04:38PM	BillionToOne: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance (GlobeNewswire)
Feb-27-26 03:40AM	BillionToOne (BLLN) Launches Two New Add-ons for Northstar Select (Insider Monkey) +6.89%
Feb-17-26 08:05AM	BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 (GlobeNewswire) +5.16%
Feb-10-26 09:00AM	BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select (PR Newswire)
Feb-09-26 12:29PM	BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care (PR Newswire)
Jan-23-26 10:23AM	Class of 2025 IPOs: 3 Stocks With Bullish Charts (Barrons.com)
Jan-15-26 08:58AM	BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare (PR Newswire)
Jan-13-26 09:43AM	What's Going On With BillionToOne Shares Tuesday? (Benzinga)
04:24AM	BillionToOne Showcases Single-Molecule NGS at JPMorgan, Lifts 202526 Revenue Outlook (MarketBeat)
Jan-12-26 08:05AM	BillionToOne Provides Guidance for 2026 (GlobeNewswire) +15.37%
Jan-06-26 09:00AM	BillionToOne Announces Selection of Northstar Select as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East (PR Newswire)
Jan-01-26 12:13AM	2 New IPO Stocks Enter the Fray; J.P. Morgan Says Buy (TipRanks)
Dec-23-25 08:05AM	BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -9.57%
Dec-09-25 04:07PM	BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair (PR Newswire) -5.32%
04:05PM	BillionToOne Reports Third Quarter 2025 Results (GlobeNewswire)
07:10AM	Medline seeks $5.37bn in largest healthcare IPO of 2025 (Medical Device Network)
Dec-03-25 04:00PM	AppLovin Stock Rides Swarm Of Setups Beyond Just Mining, Medical Names (Investor's Business Daily) -10.58%
Dec-02-25 08:05AM	BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 (GlobeNewswire)
Dec-01-25 12:16PM	BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution (Investing.com) -13.17%
09:46AM	Carvana initiated, Zscaler downgraded: Wall Street's top analyst calls (The Fly)
Nov-26-25 12:59PM	IPO Stock Taps Massive Medicare Market, Soars Into Buy Range (Investor's Business Daily)
Nov-25-25 05:00PM	IPO Stock Taps Massive Medicare Market, Soars Into Buy Range (Investor's Business Daily) +8.32%
Nov-18-25 12:34AM	Jim Cramer Says BillionToOne Has a "Fantastic Story" Within the Diagnostics Space (Insider Monkey) +6.41%
Nov-07-25 04:05PM	BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -8.18%
Nov-06-25 05:02PM	Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering (PR Newswire)
03:39PM	What Shutdown? The IPO Window Is Still Open for Some Companies (Barrons.com)
Nov-05-25 09:53PM	BillionToOne Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lynch Thomas P.	See Remarks	Oct 13 '26	Option Exercise	8.65	2,000	17,300	10,700	Oct 19 07:35 PM
Atay Oguzhan	Chairman and CEO	Oct 15 '26	Option Exercise	2.80	5,150	14,420	5,150	Oct 16 07:00 PM
Atay Oguzhan	Chairman and CEO	Oct 14 '26	Option Exercise	2.80	3,183	8,912	3,183	Oct 16 07:00 PM
Atay Oguzhan	Chairman and CEO	Oct 15 '26	Sale	100.23	5,150	516,189	0	Oct 16 07:00 PM
Atay Oguzhan	Chairman and CEO	Oct 14 '26	Sale	98.34	3,183	313,020	0	Oct 16 07:00 PM
Atay Oguzhan	Chairman and CEO	Oct 14 '26	Sale	98.00	2,667	261,366	149,168	Oct 16 07:00 PM
Atay Oguzhan	Officer	Oct 15 '26	Proposed Sale	100.23	5,150	516,189		Oct 15 04:33 PM
Atay Oguzhan	Chairman and CEO	Oct 12 '26	Option Exercise	2.80	16,667	46,668	16,667	Oct 14 06:10 PM
Atay Oguzhan	Chairman and CEO	Oct 12 '26	Sale	93.79	16,667	1,563,124	0	Oct 14 06:10 PM
Atay Oguzhan	Chairman and CEO	Oct 12 '26	Sale	97.61	2,667	260,326	151,835	Oct 14 06:10 PM
Atay Oguzhan	Officer	Oct 14 '26	Proposed Sale	98.34	3,183	313,020		Oct 14 04:19 PM
Atay Oguzhan	Member of immediate family of	Oct 14 '26	Proposed Sale	98.00	2,667	261,366		Oct 14 12:32 PM
Lynch Thomas P.	See Remarks	Oct 08 '26	Option Exercise	8.65	8,000	69,200	8,700	Oct 13 06:39 PM
Atay Oguzhan	Member of immediate family of	Oct 12 '26	Proposed Sale	97.61	2,667	260,326		Oct 13 09:00 AM
Atay Oguzhan	Officer	Oct 12 '26	Proposed Sale	93.79	16,667	1,563,125		Oct 13 08:51 AM
ten Bosch John Roderick	SVP of Laboratory Operations	Oct 05 '26	Sale	105.15	2,834	297,995	19,385	Oct 07 07:56 PM
Tsao David	Chief Technology Officer	Oct 05 '26	Option Exercise	2.80	20,000	56,000	21,000	Oct 07 07:56 PM
Tsao David	Chief Technology Officer	Oct 05 '26	Sale	108.15	20,000	2,162,950	1,000	Oct 07 07:56 PM
Tsao David	Officer	Oct 05 '26	Proposed Sale	108.15	20,000	2,162,951		Oct 05 04:10 PM
ten Bosch John Roderick	Officer	Oct 05 '26	Proposed Sale	105.15	2,834	297,995		Oct 05 01:46 PM
Tsao David	Officer	Oct 05 '26	Proposed Sale	105.15	1,750	184,012		Oct 05 10:50 AM
Atay Oguzhan	Chairman and CEO	Sep 28 '26	Option Exercise	2.80	8,333	23,332	8,333	Sep 30 08:33 PM
Atay Oguzhan	Chairman and CEO	Sep 28 '26	Sale	120.64	8,333	1,005,293	0	Sep 30 08:33 PM
Atay Oguzhan	Chairman and CEO	Sep 28 '26	Sale	120.64	2,666	321,626	154,502	Sep 30 08:33 PM
Tsao David	Chief Technology Officer	Sep 24 '26	Option Exercise	2.80	3,333	9,332	4,333	Sep 28 05:57 PM
Tsao David	Chief Technology Officer	Sep 24 '26	Sale	125.00	3,333	416,625	1,000	Sep 28 05:57 PM
ten Bosch John Roderick	SVP of Laboratory Operations	Sep 24 '26	Sale	120.00	1,416	169,920	22,219	Sep 28 05:56 PM
Atay Oguzhan	Member of immediate family of	Sep 28 '26	Proposed Sale	120.64	2,666	321,626		Sep 28 11:37 AM
Atay Oguzhan	Officer	Sep 28 '26	Proposed Sale	120.64	8,333	1,005,293		Sep 28 11:30 AM
Tsao David	Officer	Sep 24 '26	Proposed Sale	125.00	3,333	416,625		Sep 24 05:02 PM
ten Bosch John Roderick	Officer	Sep 24 '26	Proposed Sale	120.00	1,416	169,920		Sep 24 02:17 PM
ten Bosch John Roderick	SVP of Laboratory Operations	Sep 21 '26	Sale	106.61	1,416	150,960	23,635	Sep 23 05:50 PM
Lynch Thomas P.	See Remarks	Sep 17 '26	Option Exercise	13.61	35,112	477,898	35,812	Sep 21 07:00 PM
Lynch Thomas P.	See Remarks	Sep 17 '26	Sale	110.33	35,112	3,873,966	700	Sep 21 07:00 PM
ten Bosch John Roderick	Officer	Sep 21 '26	Proposed Sale	106.61	1,416	150,960		Sep 21 03:00 PM
Lynch Thomas P.	Officer	Sep 17 '26	Proposed Sale	110.33	35,112	3,873,966		Sep 17 04:20 PM
Atay Oguzhan	Chairman and CEO	Sep 14 '26	Option Exercise	2.80	24,999	69,997	24,999	Sep 16 06:43 PM
Atay Oguzhan	Chairman and CEO	Sep 14 '26	Sale	100.32	24,999	2,507,908	0	Sep 16 06:43 PM
Atay Oguzhan	Chairman and CEO	Sep 14 '26	Sale	98.00	5,332	522,536	157,168	Sep 16 06:43 PM
Atay Oguzhan	Officer	Sep 14 '26	Proposed Sale	100.32	24,999	2,507,908		Sep 14 04:35 PM
Atay Oguzhan	Member of immediate family of	Sep 14 '26	Proposed Sale	98.00	5,332	522,536		Sep 14 11:56 AM
ten Bosch John Roderick	SVP of Laboratory Operations	Sep 09 '26	Sale	97.54	1,416	138,117	25,051	Sep 11 06:01 PM
Tsao David	Chief Technology Officer	Sep 09 '26	Option Exercise	2.80	20,000	56,000	21,000	Sep 11 06:01 PM
Tsao David	Chief Technology Officer	Sep 09 '26	Sale	98.77	20,000	1,975,400	1,000	Sep 11 06:01 PM
Lynch Thomas P.	See Remarks	Sep 08 '26	Option Exercise	13.61	20,000	272,200	20,700	Sep 10 07:44 PM
Lynch Thomas P.	See Remarks	Sep 08 '26	Sale	99.99	20,000	1,999,880	700	Sep 10 07:44 PM
Tsao David	Officer	Sep 09 '26	Proposed Sale	97.54	1,750	170,695		Sep 09 12:20 PM
Tsao David	Officer	Sep 09 '26	Proposed Sale	102.27	20,000	2,045,326		Sep 09 11:57 AM
ten Bosch John Roderick	Officer	Sep 09 '26	Proposed Sale	97.54	1,416	138,117		Sep 09 11:31 AM
Lynch Thomas P.	Officer	Sep 08 '26	Proposed Sale	99.24	20,000	1,984,800		Sep 08 01:52 PM
Tsao David	Chief Technology Officer	Aug 25 '26	Option Exercise	2.80	10,000	28,000	11,000	Aug 27 08:19 PM
Tsao David	Chief Technology Officer	Aug 25 '26	Sale	100.00	10,000	1,000,000	1,000	Aug 27 08:19 PM
ten Bosch John Roderick	SVP of Laboratory Operations	Aug 25 '26	Sale	100.00	1,417	141,700	26,467	Aug 27 08:19 PM
Tsao David	Officer	Aug 25 '26	Proposed Sale	100.00	10,000	1,000,000		Aug 25 04:22 PM
ten Bosch John Roderick	Officer	Aug 25 '26	Proposed Sale	100.00	1,417	141,700		Aug 25 04:10 PM
ten Bosch John Roderick	SVP of Laboratory Operations	Aug 10 '26	Sale	92.86	1,417	131,583	27,884	Aug 12 06:55 PM
Tsao David	Chief Technology Officer	Aug 10 '26	Option Exercise	2.80	10,000	28,000	11,000	Aug 12 06:51 PM
Tsao David	Chief Technology Officer	Aug 10 '26	Sale	92.86	10,000	928,600	1,000	Aug 12 06:51 PM
ten Bosch John Roderick	Officer	Aug 10 '26	Proposed Sale	92.86	1,417	131,583		Aug 10 03:17 PM
Tsao David	Officer	Aug 10 '26	Proposed Sale	92.86	3,500	325,010		Aug 10 03:11 PM
Tsao David	Officer	Aug 10 '26	Proposed Sale	92.86	10,000	928,600		Aug 10 11:38 AM
Atay Oguzhan	Chairman and CEO	Aug 05 '26	Option Exercise	2.80	15,539	43,509	15,539	Aug 07 04:02 PM
Atay Oguzhan	Chairman and CEO	Aug 05 '26	Sale	150.03	15,539	2,331,352	0	Aug 07 04:02 PM
Atay Oguzhan	Chairman and CEO	Aug 03 '26	Option Exercise	2.80	32,500	91,000	32,500	Aug 05 08:52 PM
Atay Oguzhan	Chairman and CEO	Aug 03 '26	Sale	136.95	32,500	4,450,835	0	Aug 05 08:52 PM
Atay Oguzhan	Chairman and CEO	Aug 03 '26	Sale	137.37	12,500	1,717,125	162,500	Aug 05 08:52 PM
Atay Oguzhan	Officer	Aug 05 '26	Proposed Sale	150.03	15,539	2,331,352		Aug 05 04:56 PM
Sakakibara Shan Riku	Chief Product Officer	Jul 31 '26	Sale	140.21	4,000	560,840	200,000	Aug 04 04:32 PM
Atay Oguzhan	Officer	Aug 03 '26	Proposed Sale	137.37	2,500	343,425		Aug 03 12:45 PM
Atay Oguzhan	Member of immediate family of	Aug 03 '26	Proposed Sale	137.37	12,500	1,717,125		Aug 03 12:25 PM
Atay Oguzhan	Officer	Aug 03 '26	Proposed Sale	138.11	32,500	4,488,575		Aug 03 12:01 PM
Sakakibara Shan Riku	Officer	Jul 31 '26	Proposed Sale	140.21	4,000	560,840		Jul 31 11:00 AM
Johnson Nancy JoAnn	See Remarks	Jul 16 '26	Sale	128.29	14,199	1,821,628	6,900	Jul 20 07:38 PM
Johnson Nancy JoAnn	Officer	Jul 16 '26	Proposed Sale	128.29	14,199	1,821,628		Jul 16 04:25 PM
ten Bosch John Roderick	SVP of Laboratory Operations	Jul 13 '26	Sale	125.46	4,251	533,330	29,301	Jul 15 04:38 PM
Tsao David	Chief Technology Officer	Jul 13 '26	Option Exercise	2.80	20,000	56,000	21,000	Jul 15 04:38 PM
Tsao David	Chief Technology Officer	Jul 13 '26	Sale	124.88	20,000	2,497,698	1,000	Jul 15 04:38 PM
Atay Oguzhan	Chairman and CEO	Jul 09 '26	Option Exercise	2.80	12,500	35,000	12,500	Jul 13 04:39 PM
Atay Oguzhan	Chairman and CEO	Jul 09 '26	Sale	126.10	12,500	1,576,276	0	Jul 13 04:39 PM
Sakakibara Shan Riku	Chief Product Officer	Jul 09 '26	Option Exercise	29.82	4,000	119,269	212,000	Jul 13 04:39 PM
Sakakibara Shan Riku	Chief Product Officer	Jul 09 '26	Sale	125.00	8,000	1,000,000	204,000	Jul 13 04:39 PM
Tsao David	Officer	Jul 13 '26	Proposed Sale	12.52	20,000	250,498		Jul 13 04:13 PM
ten Bosch John Roderick	Officer	Jul 13 '26	Proposed Sale	125.46	4,251	533,330		Jul 13 10:17 AM
Tsao David	Officer	Jul 13 '26	Proposed Sale	125.46	3,500	439,110		Jul 13 10:04 AM
Atay Oguzhan	Officer	Jul 09 '26	Proposed Sale	126.10	12,500	1,576,276		Jul 09 04:15 PM
Sakakibara Shan Riku	Officer	Jul 09 '26	Proposed Sale	125.00	8,000	1,000,000		Jul 09 12:59 PM
Atay Oguzhan	Chairman and CEO	Jul 06 '26	Option Exercise	2.80	26,250	73,500	26,250	Jul 08 07:06 PM
Atay Oguzhan	Chairman and CEO	Jul 06 '26	Sale	122.05	26,250	3,203,733	0	Jul 08 07:06 PM
Atay Oguzhan	Chairman and CEO	Jul 06 '26	Sale	122.05	12,500	1,525,646	175,000	Jul 08 07:06 PM
Johnson Nancy JoAnn	See Remarks	Jul 01 '26	Sale	124.91	801	100,056	21,099	Jul 06 08:38 PM
Atay Oguzhan	Member of immediate family of	Jul 06 '26	Proposed Sale	122.05	12,500	1,525,646		Jul 06 04:21 PM
Atay Oguzhan	Officer	Jul 06 '26	Proposed Sale	120.00	26,250	3,150,000		Jul 06 03:18 PM
Atay Oguzhan	Officer	Jul 06 '26	Proposed Sale	120.00	2,500	300,000		Jul 06 12:19 PM
ten Bosch John Roderick	SVP of Laboratory Operations	Jun 29 '26	Sale	120.00	1,416	169,920	33,552	Jul 01 04:23 PM
Johnson Nancy JoAnn	Officer	Jul 01 '26	Proposed Sale	124.91	801	100,056		Jul 01 04:18 PM
ten Bosch John Roderick	Officer	Jun 29 '26	Proposed Sale	120.00	1,416	169,920		Jun 29 11:20 AM
Sakakibara Shan Riku	Chief Product Officer	Jun 24 '26	Option Exercise	8.65	4,000	34,600	216,000	Jun 26 05:20 PM
Sakakibara Shan Riku	Chief Product Officer	Jun 24 '26	Sale	110.00	8,000	880,000	208,000	Jun 26 05:20 PM
Sakakibara Shan Riku	Officer	Jun 24 '26	Proposed Sale	110.00	8,000	880,000		Jun 24 12:50 PM
ten Bosch John Roderick	See Remarks	Jun 15 '26	Sale	101.47	2,832	287,363	34,968	Jun 17 05:47 PM

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.

Co-FounderDr. Oguzhan Atay Ph.D.

Co-FounderDr. David Tsao Ph.D.

Chief Administrative OfficerMr. John D. Lister J.D.

M.B.A.Mr. Ross Taylor Jr.

VP of Business Operations & Chief of StaffMs. Jean Hayden

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BLLN

Billiontoone Inc

Upgrade your Finviz experience